// STATE LEGISLATION TRACKER

Alabama SR 22: SPECIAL ORDER CALENDAR

⚖️ NEUTRAL for peptide users 👤 NONE user impact 📜 Status: Introduced

State: Alabama
Bill: SR 22
Session: 2026rs
Filed: 2024-02-27
Read the bill: OpenStates →
Last reviewed: 2026-10-05

Plain-English Summary

Alabama SR22 is a Senate scheduling resolution, not a health care or drug policy bill. Based on the title, subjects, and available bill text, it does not change peptide prescribing, compounding, telehealth, NP scope, naturopathic practice, controlled substances, or prescription monitoring.

Key Points

No direct change to compounded peptide access
No new rule for off-label prescribing or telehealth
No change to NP or naturopathic scope of practice
No FDA 503A/503B compounding language identified
No controlled-substance or PDMP change identified

What to Watch For

Note This is a procedural calendar resolution, so any peptide impact would come only from a separate listed bill.

Note If a listed bill is later amended into health care or pharmacy policy, review that bill directly.

Where the Bill Stands

The bill information provided says SR22 was introduced; the available text is a Senate special-order calendar, not a policy bill.

· Ed. Our analysis pulls public bill metadata from OpenStates and is enriched with research-model context. We don't quote bill text we haven't read directly. If this bill matters to your practice or treatment access, read the official source linked above before taking action. We're an educational research directory, not a legal or medical reference.

Bill page generated 2026-11-04 · enriched via codex gpt-5.5
Source: OpenStates v3 API · View official bill · ← back to all laws